AIVITA Biomedical, Inc.

Biopharma leaders anticipate tackling COVID-19 will remain the top priority at least for the next few months. However, as Anne Heatherington , head of Takeda Pharmaceutical Co. Ltd. 's Data Sciences

The week before the annual J.P. Morgan Healthcare Conference always includes a bevy of new financings and the week before this year’s 11-14 January meeting kept up with the tradition with $1.67bn in v

Derived from Strategic Transactions , Informa’s premium source for tracking life science deal activity, Venture Funding Deals provides a comprehensive monthly review of emerging biopharmaceutical com

The Dementia Discovery Fund (DDF) brought together government, nonprofit, venture capital and industry investors starting in 2015 with the goal of funding early-stage development of disease-modifying